These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1605591)

  • 1. Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4.
    Chams V; Idziorek T; Maddon PJ; Klatzmann D
    Antimicrob Agents Chemother; 1992 Feb; 36(2):267-72. PubMed ID: 1605591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
    Xie H; Ng D; Savinov SN; Dey B; Kwong PD; Wyatt R; Smith AB; Hendrickson WA
    J Med Chem; 2007 Oct; 50(20):4898-908. PubMed ID: 17803292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
    Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
    J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    Moore JP
    AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
    Pandey D; Podder A; Pandit M; Latha N
    J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.
    Clancy J; Tait-Kamradt A; Petitpas J; Manousos M; McGuirk PR; Subashi T; Watts P; Wondrack L
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2008-13. PubMed ID: 7811011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M; Furman C; Helseth E; Repke H; Sodroski J
    J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics.
    Moraca F; Acharya K; Melillo B; Smith AB; Chaiken I; Abrams CF
    J Chem Inf Model; 2016 Oct; 56(10):2069-2079. PubMed ID: 27602436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    Thali M; Olshevsky U; Furman C; Gabuzda D; Li J; Sodroski J
    J Virol; 1991 Sep; 65(9):5007-12. PubMed ID: 1870209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
    Hager-Braun C; Tomer KB
    Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus.
    Doyle CB; Bhattacharyya U; Kent KA; Stott JE; Jones IM
    J Virol; 1995 Feb; 69(2):1256-60. PubMed ID: 7815501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
    Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
    J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.
    Batinić D; Robey FA
    J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.